Pekin Hardy Strauss Inc. Increases Stock Position in Humana Inc. (NYSE:HUM)

Pekin Hardy Strauss Inc. lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 5.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,584 shares of the insurance provider’s stock after acquiring an additional 1,735 shares during the period. Humana accounts for about 1.1% of Pekin Hardy Strauss Inc.’s holdings, making the stock its 16th biggest position. Pekin Hardy Strauss Inc.’s holdings in Humana were worth $8,521,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Creative Financial Designs Inc. ADV grew its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the last quarter. FPC Investment Advisory Inc. purchased a new position in Humana in the 4th quarter valued at $27,000. Centricity Wealth Management LLC purchased a new position in Humana in the 4th quarter valued at $30,000. Ashton Thomas Securities LLC purchased a new position in Humana in the 3rd quarter valued at $31,000. Finally, Your Advocates Ltd. LLP boosted its position in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Trading Down 5.7 %

Shares of HUM stock opened at $255.77 on Friday. The firm has a 50-day moving average price of $269.41 and a 200 day moving average price of $290.00. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a market capitalization of $30.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.05 and a beta of 0.56. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.38%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is 35.58%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on HUM shares. Piper Sandler boosted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. Wells Fargo & Company decreased their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley decreased their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Finally, Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $285.68.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.32% of the stock is owned by company insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.